Mustafa Abubaker

Mustafa Abubaker

Auto-generated profile, based on publicly available information

Mustafa Abubaker

Faculty of Medical laboratory Sciences

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2020 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
MEMustafa Elhag
Mustafa Elhag
RARuaa Mohamed Alaagib
Ruaa Mohamed Alaagib
NANagla Mohamed Ahmed
Nagla Mohamed Ahmed
MAMustafa Abubaker
Mustafa Abubaker
EHEsraa Musa Haroun
Esraa Musa Haroun
MHMohsmedahamed Hassan
Mohsmedahamed Hassan
Pseudomonas aeruginosa is a common pathogen that is responsible for serious hospital-acquired infections, ventilator-associated pneumonia, and various sepsis syndromes. Also, it is a multidrug-resistant pathogen recognized for its ubiquity and its intrinsically advanced antibiotic-resistant mechanisms. It usually affects immunocompromised individuals but can also infect immunocompetent individuals. There is no vaccine against it available till now. This study predicts an effective epitope-based vaccine against fructose bisphosphate aldolase (FBA) of Pseudomonas aeruginosa using immunoinformatics tools. The protein sequences were obtained from NCBI, and prediction tests were undertaken to analyze possible epitopes for B and T cells. Three B cell epitopes passed the antigenicity, accessibility, and hydrophilicity tests. Six MHC I epitopes were found to be promising, while four MHC II epitopes were found promising from the result set. Nineteen epitopes were shared between MHC I and II results. For the population coverage, the epitopes covered 95.62 worldwide excluding certain MHC II alleles. We recommend in vivo and in vitro studies to prove its effectiveness.

27 May 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
MEMustafa Elhag
Mustafa Elhag
MAMustafa Abubaker
Mustafa Abubaker
NANagla Mohammad Ahmad
Nagla Mohammad Ahmad
EHEsraa Musa Haroon
Esraa Musa Haroon
RARuaa Mohamed Alaagib
Ruaa Mohamed Alaagib
MHMohammed A. Hassan
Mohammed A. Hassan
Listeria Monocytogenes represents an important food-borne pathogen worldwide that can cause life-threatening listeriosis disease especially in pregnant women, fetuses, elderly people, and immuno-compromised individuals with high mortality rates. Moreover, no vaccine against it exists. This study predicts an effective epitope-based vaccine against Fructose 1,6 Bisphosphate Aldolase (FBA) enzyme of Listeria Monocytogenes using immunoinformatics approaches. The sequences were retrieved from NCBI and several prediction tests were conducted to analyze possible epitopes for B-cell, T-cell MHC class I and II. 3D structure of the promising epitopes was obtained. Two epitopes showed high binding affinity for B-cells, while four epitopes showed high binding affinity for MHCI and MHCII. The results were promising to formulate a vaccine with more than 98% population coverage. We hope that these promising epitopes serves as a preventive measure for the disease in the future and recommend invivo and invitro studies.